This site is intended for healthcare professionals only
LoginRegister
Bayer Nubeqa gets EU approvalCDSCO Panel Approves Bayer's Real-World Use Study for Heart Failure Drug Vericiguat
CDSCO Panel Clears AstraZenecas Datopotamab for Breast Cancer, Seeks Phase IV TrialCDSCO Panel Approves Updated Prescribing Information for AstraZeneca's Rosuvastatin (Crestor)
Sanofi Rilzabrutinib earns orphan designation in EU for IgG4 related diseaseSanofi launches 2025 Global Employee Stock Purchase Plan
Bayer Nubeqa gets EU approvalBayer arm secures exclusive worldwide rights to develop, commercialize clinical-stage WRN Inhibitor
Lupin to Conduct BE Study for Synthetic Semaglutide Tablets in 3 StrengthsLupin bags tentative nod from USFDA for partial-onset seizures drug Oxcarbazepine ER
Eye condition NAION is a very rare side effect of semaglutide: EMA safety committeeEMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy
Wockhardt seeks DCGI nod for ZaynichWockhardt seeks DCGI nod for Zaynich
Reckitt names Ravi B as Director Corporate Communications and Corporate Affairs ( South Asia, MENARP and Africa)Reckitt names Ravi Bhatnagar as Director Corporate Communications and Corporate Affairs (South Asia,...
Do Not Issue Licenses Without New Drug Permission from DCGI, Govt Panel Tells StatesSuspected spurious drugs worth Rs 5.21 lakh seized in Hyderabad
Regulatory Roadblock for Zydus: CDSCO Panel Halts MMRV Vaccine Trial, Seeks Adult DataZydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million
AstraZeneca collaborates with CSPC Pharma focused on AI-enabled researchAstraZeneca Calquence based regimens approved in EU for previously untreated chronic lymphocytic...
Bayer, Kumquat Biosciences ink pact to develop, commercialize KRAS G12D inhibitorBristol Myers Squibb, BioNTech ink pact to co-develop, co-commercialize investigational bispecific...
X